Quality Assurance and Control. 9.4.1. ACRO employ strict quality control procedures and staff undertaking this work are all appropriately trained.
9.4.2. On a monthly basis ACRO can, if required, provide regular management information to the GLAA including: • Number of PNC Updates required • Details of any cases that fall outside agreed ‘Service Levels’ • Number of issues and/or disputes • Number of International Requests
Quality Assurance and Control. The Site Parties shall permit the Study Monitor, Auditor and any official with a legal right to inspect and access all relevant documentation and source data for monitoring of the progress of the Clinical Study, the proper collection and recording of Clinical Study data, the welfare of the Clinical Study Subjects, and altogether the good quality of the Clinical Study and compliance with applicable Law and, if applicable and communicated to the Site Parties in writing, Sponsor’s standard operating procedures. The Study Monitor and Auditor’s access will be arranged at mutually convenient times and on reasonable notice with no additional costs for the Study Monitor, Auditor or Sponsor. The Study Monitor and Auditor will comply with all internal policies and regulations of the Site Parties during such inspection, to the extent these are sufficiently communicated to the Study Monitor or Auditor. For the avoidance of any doubt, the Sponsor shall be responsible for the confidential handling of all Personal Data of Clinical Study Subjects and other patients which the Study Monitor or Auditor comes across with during their monitoring or auditing activities. Before the start of the monitoring or auditing visits, the Sponsor shall provide the Site Parties with the name of the appointed Study Monitor or auditor, and hereby warrants (in Dutch: “staat garant”) that such Study Monitor or Auditor shall timely sign a confidentiality statement regarding the above by means of a specific letter. of the template for such letter is annexed to this Agreement below, as Annex 4. The Site Parties shall promptly inform the Sponsor in writing of any intended or actual inspection, written enquiry and/or visit to the Site Parties by any regulatory authority in connection with the Clinical Study and forward to the Sponsor copies of any correspondence from any such regulatory authority relating to the Clinical Study. The Site Parties shall allow Sponsor’s representatives to be present during any such visit. The Site Parties shall take appropriate measures and/or corrective actions without delay as the Sponsor may reasonably require in order to solve all problems found and reported by the Study Monitors, Auditor or officers from regulatory authorities or during an inspection under clause 6.2. The Site Parties shall permit authorized representatives of the Ethics Committee and Competent Authorities to have access to and verify information relating to the Clinical Study, as required by and ...
Quality Assurance and Control. 1. Contractor shall:
a) Ensure services shall be in accordance with standards set by the American National Standards Institute (ANSI) and Association for Information and Image Management (AIIM) and Government Code section 26205.1.
b) Provide to County samples of documents converted to appropriate media within 30 working days of contract award for the purpose of establishing Quality Benchmarks. Additionally, prior to the start of any new Agency/Department engagement or project, representative samples as specified above will be provided to Agency/Department. County and Contractor will meet and jointly agree as to the subjective measurement(s) for acceptable image quality.
c) Return scanned media on no less than a weekly basis.
d) Provide County with a weekly report that indicates work received from each Agency/Department. This report shall include the time received, the type and volume of work.
e) Perform adequate quality assurance so that the index data is 99 % accurate at the field level.
f) Be subject to random quality checks of all Services. When the image quality encountered by County during a random inspection is poor or marginal, County shall compare this image to the previously accepted benchmark sample. If the document image in question is equal to or of better quality than the benchmark sample then the document will be accepted; if not, the document (image) along with all images contained in the same file folder will be rejected and re-scanned by Contractor. If Contractor is repeatedly unable to produce acceptable image quality from documents determined to be acceptable in the benchmark test, County shall issue a cure notice asking Contractor to explain how they are going to rectify the problem. If Contractor's response is not satisfactory, County shall have the right to terminate the contract for default. After rejecting a file, the applicable Agency/Department representative may inspect at least ten (10) additional document scans both before and after any corrective actions have been taken. If this inspection results in another rejection of an image or file, then the entire batch may be rejected.
g) Ensure that any document that is regarded as poor quality will be compared to the quality sample provided by County. Images not meeting this quality level may be cause for rejection by County unless Contractor can prove that it has provided the best image possible based upon the original document.
2. Contractor must provide a Quality Assurance Plan. T...
Quality Assurance and Control. In an effort to ensure that the Consultant provides high quality work, the Client will assign the CEO of the Client company to review and approve the work of the Consultant. In the event that the Consultant uses a third party, the Consultant is responsible for the quality of the work delivered by the third party.
Quality Assurance and Control. 9.4.1. ACRO employ strict quality control procedures and staff undertaking this work are all appropriately trained.
Quality Assurance and Control. 7.7.1 ACRO employs strict quality control procedures and staff undertaking this work will be appropriately trained.
7.7.2 On a monthly basis ACRO can, if required by TM EYE / EMM, provide regular management information which may include:
Quality Assurance and Control. 6.1. The Site Parties shall ensure that all procedures defined in the Protocol are complied with, so that all data generated at the Trial Site are reliable and have been processed correctly (especially the randomization lists, and the blind character of the Clinical Trial as the case may be) and will ensure that the content of the CRFs or e-CRFs will accurately reflect source documents.
6.2. The Site Parties will permit the Sponsor to examine the conduct of the Clinical Trial and the Trial Site upon reasonable advance notice and in the company of a Site Party’s representative, during regular business hours at mutually agreed times, and at Sponsor's sole expense to determine that the Clinical Trial is being conducted in accordance with the Protocol, this Agreement and applicable Law, provided Trial Monitor will comply with all internal policies and regulations of the Trial Site to the extent these are sufficiently communicated to the Trial Monitor.
6.3. The Site Parties shall permit the Trial Monitor and any Auditor access to all relevant clinical data of Clinical Trial Subjects and relevant source documents for monitoring of the progress of the Clinical Trial, the proper collection and recording of Clinical Trial data, the welfare of the Clinical Trial Subjects, and altogether the good quality of the Clinical Trial and compliance with applicable Law and Sponsor’s and/or CRO’s Standard Operating Procedures. For the avoidance of any doubt, the Sponsor shall be responsible for the confidential handling of all Personal Data of Clinical Trial Subjects and other patients which the Trial Monitor and any Auditor comes across with during its monitoring or auditing activities. Before the start of the monitoring visits, the Sponsor shall provide the Institution with the name and date of birth of the appointed monitor, and declare that such Trial Monitor has signed a confidentiality statement regarding the above.
6.4. The Site Parties shall promptly inform the Sponsor and/or CRO of any intended or actual inspection, written enquiry and/or visit to the Trial Site by any regulatory authority in connection with the Clinical Trial and forward to the Sponsor copies of any correspondence from any such regulatory authority relating to the Clinical Trial. The Site Parties shall allow Sponsor and/or CRO representatives to be present during any such visit as permitted by Law.
6.5. The Site Parties shall permit authorized representatives of the Ethics Committee and Competent Aut...
Quality Assurance and Control. Licensee will perform quality assurance inspections to assure the compliance of the Licensed Products with the product specifications set forth in any purchase order and to meet all applicable health and safety requirements. Licensee will maintain separate lot code control for every batch produced and maintain a file recording where all products by lot code where shipped. Licensee shall retain samples of each batch of Licensed Products produced and filled for a period of no less than two (2) years. Licensee shall ensure that any Manufacturers and any and all raw material suppliers maintain a quality control program consistent with Applicable Law.
Quality Assurance and Control. 4.1 Supplier shall have an implemented and documented quality assurance system in accordance with ISO 9000 or equivalent.
4.2 Buyer has the right but not the obligation to make the verifications, inspections and tests, including audits, at Supplier’s and subcontractor’s facility, in order to satisfy itself that the Goods will be manufactured according to the requirements in the Purchase Order. Buyer can either do the work itself, or through third party given the necessary authority. Supplier and if applicable subcontractor are obliged to assist in connection with inspections and tests without any cost to Buyer and shall also present all issued Test Reports, Material Certificates, Calculations etc. upon Buyer’s demand.
4.3 If faults and omissions are pointed out as a result of inspect- ions/tests Supplier shall without delay rectify these at its own cost.
4.4 The above mentioned inspections and verifications carried out or not do not exempt Supplier from any risk or the responsibility to deliver the Goods in accordance with the Purchase Order.
4.5 Supplier shall verify that any subcontractor to the Purchase Order has an implemented and documented quality assurance system.
4.6 Supplier shall not assign the Purchase Order or subcontract any part of same without Buyer’s prior written approval.
Quality Assurance and Control. 10.4.1. ACRO employ strict quality control procedures and staff undertaking this work are all appropriately trained.
10.4.2. On a monthly basis ACRO can, if required, provide regular management information to the Probation Board of Northern Ireland (PBNI) including: • Number of PNC ‘Names Enquiry’ forms received • Number of PNC Disclosure Prints provided • Details of any cases that fall outside agreed ‘Service Levels’ • Number of issues and/or disputes • Number of International Requests
